Angiography-Based Index of Microcirculatory Resistance in Assessing the MVO and Infarct Size in STEMI Patients.
Tian Wu, Xiaojiao Zhang, Chen Li et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the angiography-based index of microcirculatory resistance (angio-IMR) in 123 STEMI patients to assess microvascular obstruction (MVO) and infarct size (IS). The study found that the recombinant staphylokinase (r-SAK) group had numerically lower post-PCI angio-IMR (39.12 U vs. 42.57 U) and MVO (54.0% vs. 70.9%) compared to the normal saline group, indicating potential benefits of r-SAK in reducing microvascular injury.
Key findings
- Post-PCI angio-IMR was 39.12 U in the r-SAK group compared to 42.57 U in the NS group (p=0.567).
- MVO occurred in 54.0% of the r-SAK group versus 70.9% in the NS group (p=0.059).
- Angio-IMR showed a positive correlation with MVO extent (ρ=0.347; p<0.001) and IS (ρ=0.324; p<0.001).
- The AUC for angio-IMR in diagnosing MVO was 0.750 (p<0.001).
Why it matters
Understanding the role of angio-IMR in assessing microvascular obstruction and infarct size can help clinicians better evaluate treatment efficacy in STEMI patients, potentially guiding therapeutic decisions and improving patient outcomes.